Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

NCT04618367 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT04618367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04618367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Lead sponsor
Sun Yat-sen University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2021
Completion date
December 30, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular, liver neoplasms, portal vein tumor thrombus, sintilimab